Population pharmacokinetics (Pop PK) of MYL-1402O (a proposed biosimilar to bevacizumab) and reference product (Avastin) in patients with nonsquamous non-small cell lung cancer (nsNSCLC). Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Owen, Joel; Rackley, Russell J.; Hummel, Matthew A.; Roepcke, Stefan; Huang, Hannah; Liu, Mark S.; Idris, Tazeen A.; Murugesan, Sundara Moorthi Nainar; Vishweswaramurthy, Ashwini; Loganathan, Subramanian; Ranganna, Gopinath; Barve, Abhijit J.; Waller, Cornelius; Socinski, Mark A.

Publication Date

  • May 20, 2021

webpage

published in

category

volume

  • 39

issue

  • 15